CEOs from Medtronic, Boston Scientific, 3M, and more have called for deescalation in Minneapolis following two ICE-involved ...

Robert Kowal, MD, tells MD+DI how he became involved with the development of Medtronic's Micra leadless pacemaker.

A new survey reveals 20% of Gen Z use AI chatbots for STI/STD questions, but chatbots misdiagnose 31% of cases, raising ...

This week in Pedersen's POV, our senior editor examines AdvaMed's strategic approach to tariff discussions with the Trump ...

Woori IO plans to accelerate its noninvasive CGM launch after FDA announced relaxed wearable device regulations.

Medtronic won CE mark for the Affera Sphere-360 catheter and completed the first cases of the device in the Horizon 360 IDE ...

Michael “Mick” Farrell, chairman and CEO of Resmed, has begun his two-year term as the new chair of AdvaMed’s board of ...

Intuitive Surgical receives FDA clearance for the da Vinci 5 robot to be used in cardiac procedures, reports 18% procedure ...

Medtronic will invest $90M in Anteris Technologies for DurAVR TAVR device development, contingent on a $200M IPO.

According to a June 1996 article in MD+DI, two surveys that year had pegged increased investments in information technologies ...

Click Therapeutics’ CEO discusses the first FDA-cleared depression app, migraine treatment breakthrough, and digital ...